Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 12.0B | 14.2B | 12.5B | 10.4B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | 5.0B | 4.6B | 4.8B | 4.8B |
| Other operating expenses | — | — | — | — |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | — | — | — | — |
| Pretax income | 4.6B | 4.1B | 5.4B | 5.3B |
| Tax provision | 1.5B | 1.0B | 1.7B | 1.6B |
| Net income | 3.2B | 3.1B | 3.6B | 3.6B |
| Basic EPS | — | — | — | — |
| Diluted EPS | — | — | — | — |
| Basic average shares | — | — | — | — |
| Diluted average shares | — | — | — | — |
| EBITDA | — | — | — | — |
| Net income from continuing op. | 3.2B | 3.1B | 3.6B | 3.6B |
| Minority interests | -42.8M | -11.1M | -12.3M | -15.9M |
| Preferred stock dividends | — | — | — | — |